← Eichor
Study identifier: NCT04847635 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Subthreshold Laser Treatment for Reticular Pseudodrusen Secondary to Age-related Macular Degeneration

Condition: Macular Degeneration, Senile · Laser Burn of Retina · Macular Degeneration Intermediate  ·  Sponsor: Ospedale San Raffaele

PhaseNA
Planned participants50
Who can joinAll sexes, 55 Years to no upper limit
Healthy volunteersNo

About this study

Prospective, randomized, controlled, longitudinal, interventional multicentric study involving patients with reticular pseudodrusen secondary to AMD. The objective of this study is to establish the effectiveness of subthreshold laser treatment in increase/prevent the decrease of the retinal sensibility in patients with reticular pseudodrusen, and to reduce the progression of RPD to atrophy. Approximately 50 naïve patients with reticular pseudodrusen who underwent subthreshold laser treatment in perifoveal area. These patients should be randomized in the 2 study arms of the study. Patients will be evaluated at Screening/Baseline and then revaluated and retreated at month 3, 6 and 9. At month 12, all patients will be evaluated with a full ocular examination, visual acuity measurement (VA), optical coherence tomography (OCT) with autofluorescence, OCT-angiography and microperimetry. The rationale of the study is to prevent the evolution of reticular pseudodrusen to atrophic degeneration.

This description comes directly from the study's public registry record.

Talk to the study team

Giuseppe Querques, MD, PhD  ·  +390226434004  ·  querques.giuseppe@hsr.it

Always discuss trial participation with your own doctor first.

Locations (3)

Massimo NicolòGenova, ItalyRecruiting
Giuseppe QuerquesMilan, ItalyRecruiting
Mariacristina ParravanoRome, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04847635